Page last updated: 2024-11-04

roxatidine acetate and Stomach Neoplasms

roxatidine acetate has been researched along with Stomach Neoplasms in 2 studies

roxatidine acetate: structure given in first source

Stomach Neoplasms: Tumors or cancer of the STOMACH.

Research Excerpts

ExcerptRelevanceReference
" This study was designed to test the hypothesis that the H2 blockers roxatidine and ranitidine might stimulate migration and proliferation of gastric mucous cells derived from a human well-differentiated gastric adenocarcinoma cell line (MKN 28 cells) in vitro, in conditions independent of systemic factors and of acid inhibition."3.69Histamine H2-receptor antagonists stimulate proliferation but not migration of human gastric mucosal cells in vitro. ( Ciacci, C; De Luca, A; Del Vecchio Blanco, C; Mazzacca, G; Ricci, V; Romano, M; Zarrilli, R, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imaeda, H1
Hosoe, N1
Suzuki, H1
Saito, Y1
Ida, Y1
Nakamura, R1
Iwao, Y1
Ogata, H1
Hibi, T1
Ciacci, C1
Zarrilli, R1
Ricci, V1
De Luca, A1
Mazzacca, G1
Del Vecchio Blanco, C1
Romano, M1

Trials

1 trial available for roxatidine acetate and Stomach Neoplasms

ArticleYear
Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
    Journal of gastroenterology, 2011, Volume: 46, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cost-Benefit An

2011

Other Studies

1 other study available for roxatidine acetate and Stomach Neoplasms

ArticleYear
Histamine H2-receptor antagonists stimulate proliferation but not migration of human gastric mucosal cells in vitro.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:5

    Topics: Adenocarcinoma; Blotting, Northern; Cell Division; Cell Movement; Dose-Response Relationship, Drug;

1996